sujets spéciaux
S Adénosyl L Méthionine
Références
1.Galizia I, Oldani L, Macritchie K, et al: S-adenosyl methionine (SAMe) for depression in adults (review).Cochrane Database Syst Rev10:CD011286, 2016. doi: 10.1002/14651858.CD011286.pub2 2.Sarris J, Murphy J, Stough C, et al: S-adenosylmethionine (SAMe) monotherapy for depression: an 8-week double-blind, randomised, controlled trial.Psychopharmacology (Berl)237(1):209-218, 2020. doi: 10.1007/s00213-019-05358-1 3.Sarris, Byrne GJ, Bousman C, et al: Adjunctive S-adenosylmethionine (SAMe) in treating non-remittent major depressive disorder: an 8-week double-blind, randomized, controlled trial.Eur Neuropsychopharmacol.28(10):1126-1136, 2018. doi: 10.1016/j.euroneuro.2018.07.098 4.Rutjes AW, Nüesch E, Reichenbach S, et al: S-Adenosylmethionine for osteoarthritis of the knee or hip.Cochrane Database Syst Rev(4) CD007321, 2009. doi: 10.1002/14651858.CD007321.pub2 5.De Silva V, El-Metwally A, Ernst E, et al; Arthritis Research UK Working Group on Complementary and Alternative Medicines: Evidence for the efficacy of complementary and alternative medicines in the management of osteoarthritis: a systematic review.Rheumatology (Oxford)50(5):911-920, 2011. doi: 10.1093/rheumatology/keq379 6.Soeken KL, Lee WL, Bausell RB, et al: Safety and efficacy of S-adenosylmethionine (SAMe) for osteoarthritis.J Fam Pract51(5):425-430, 2002. 7.Gurung V, Middleton P, Milan SJ, et al: Interventions for treating cholestasis in pregnancy.Cochrane Database Syst Rev6:CD000493, 2013. doi: 10.1002/14651858.CD000493.pub2 8.Rambaldi A, Gluud C: S-adenosyl-L-methionine for alcoholic liver diseases.Cochrane Database Syst Rev(2):CD002235, 2006. doi: 10.1002/14651858.CD002235.pub2 9.De la Cruz JP, Mérida M, González-Correa JA, et al: Effects of S-adenosyl-L-methionine on blood platelet activation.Gen Pharmacol29(4):651-655, 1997. doi:10.1016/s0306-3623(96)00571-x 10.Papakostas GI, Mischoulon D, Shyu I, et al: S-adenosyl methionine (SAMe) augmentation of serotonin reuptake inhibitors for antidepressant nonresponders with major depressive disorder: a double-blind, randomized clinical trial.Am J Psychiatry167(8):942-948, 2010. doi:10.1176/appi.ajp.2009.09081198 